# Kowa Company, Ltd.

Organization · id `cardio:org-kowa-company-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Kowa+Company%2C+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Kowa Company, Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: TOFO Insulin Combination Trial (`cardio:ct-nct02201004`)
- Sponsors: K-924 Phase III Confirmatory Study (`cardio:ct-nct04289649`)
- Sponsors: K-924 Phase III Long Term Study (`cardio:ct-nct04289662`)
- Sponsors: A Phase III Confirmatory Study of K-877 Extended Release Tablet (`cardio:ct-nct04714151`)
- Sponsors: A Phase III Long Term Study of K-877 Extended Release Tablet (`cardio:ct-nct04716595`)
- Sponsors: A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C (`cardio:ct-nct04998981`)
- Sponsors: Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) (`cardio:ct-nct05469659`)
- Sponsors: A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins (`cardio:ct-nct07634484`)

## Provenance

Content hash: a693ca37d53324ab55838e5baac644d948deec2e8d262074245575136843fe9f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
